Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that involves not only scientific and medical expertise but also adherence to strict legal and ethical standards. This article will delve into the importance of scientific expertise in generic drug development, highlighting the key areas where scientific knowledge is essential.

Generic Drugs 98

Generic Drugs Bioequivalency Development Drugs 98

World of DTC Marketing

FEBRUARY 21, 2022

didn’t just offer to pay for the drug’s development cost so that the price could be set very low, but it’s about investors who penalized the company stock when they learned that COVID might be on the decline. At this point, one must wonder why the U.S. About those copay cards.

Regulation 218

Regulation Drugs Bioequivalency Vaccination 218

Pharmaceutical Technology

JULY 25, 2022

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. The FDA knows that developing specialty generics, particularly generic injectable products, can be challenging. The only way forward for generics producers.

Drugs 298

Drugs Manufacturing Production Marketing 298

XTalks

FEBRUARY 8, 2021

As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. Unlike small-molecule generic drugs, biosimilars do not need to demonstrate bioequivalence to the innovator product.

Production 78

Production Insulin Branding Generic Drugs 78

Drug Patent Watch

JANUARY 7, 2025

They’re designed to be bioequivalent, meaning they have the same dosage, strength, route of administration, quality, and intended use as the original brand-name drug. For example, instead of saying “bioequivalent,” you might say “works the same way in the body.” What Are Generic Drugs?

Generic Drugs 89

Generic Drugs Drugs Branding Bioequivalency 89